Today, shares of GBS (NASDAQ:GBS) are skyrocketing following news that “the company will start preparation for clinical trials of its rapid SARS-CoV-2 antibody test.” GBS’s antibody test utilizes ...
Redesigned test introduces two new targets to improve coverage and sensitivity for Group B Streptococcus intrapartum testing for pregnant females Group B Streptococcus (GBS) is the leading cause of ...
Group B streptococcus (GBS) is a bacteria about 25% of pregnant women carry. It's rare for babies to get GBS disease from their mothers during labor, but it can be very harmful. So healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback